✦ LIBER ✦

Biomarkers for trials of neuroprotection in Parkinson's disease

✍ Scribed by Pankaj A. Agarwal; A. Jon Stoessl

Book ID: 115559989
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 577 KB
Volume: 28
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.25065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Designing neuroprotection trials in Park

Designing neuroprotection trials in Parkinson's disease

✍ Karl Kieburtz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Neuroprotection in Parkinson's disease:

Neuroprotection in Parkinson's disease: Clinical trials

✍ Fabrizio Stocchi; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

Neuroprotection trials in Parkinson's di

Neuroprotection trials in Parkinson's disease: Systematic review

✍ Robert G. Hart; Lesly A. Pearce; Bernard M. Ravina; Toby C. Yaltho; John R. Marl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr

Neuroprotection in Parkinson's disease

✍ Anthony H.V. Schapira 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Neuroprotection in Parkinson's Disease

✍ Jean-Louis Montastruc; Olivier Rascol; Jean-Michel Senard 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 171 KB

Targets for neuroprotection in Parkinson

Targets for neuroprotection in Parkinson's disease

✍ Talene A. Yacoubian; David G. Standaert 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 353 KB